Arthur Sookra v. Pfizer Inc.

Court of Appeals for the D.C. Circuit·Decided July 31, 2026·No. 25-5200·Published

Opinion

United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT

Argued May 4, 2026 Decided July 31, 2026

No. 25-5200

ARTHUR SOOKRA AND APRIL BURCH-SOOKRA, ON BEHALF OF THEIR DECEASED MINOR CHILD TAYLOR ROSE SOOKRA, APPELLANTS

v.

PFIZER INC., ET AL., APPELLEES

Appeal from the United States District Court for the District of Columbia (No. 1:24-cv-01249)

E. Scott Lloyd argued the cause and filed the briefs for appellants.

Caroline W. Tan, Attorney, U.S. Department of Justice, argued the cause for federal appellees. With her on the brief were Brett A. Shumate, Assistant Attorney General, and Brad Hinshelwood, Attorney.

David J. Weiner argued the cause for appellee Pfizer, Inc. With him on the brief were William Hoffman and Sharon D. Mayo. 2

Jodi V. Terranova and Teresa Pike Tomlinson were on the response brief for appellees Mitchell Weiler, M.D. and South Island Pediatrics P.C., joining in the brief of appellee Pfizer, Inc.

Before: MILLETT, KATSAS, and WALKER, Circuit Judges.

Opinion for the Court filed by Circuit Judge MILLETT.

MILLETT, Circuit Judge: Fourteen-year-old Taylor Rose Sookra fell ill and passed away in December 2021, four months after receiving Pfizer, Inc.’s COVID-19 vaccine. Taylor’s parents, Arthur Sookra and April Burch-Sookra (collectively, “Sookras”) filed a lawsuit against certain federal-government officials and Pfizer, alleging that they engaged in willful misconduct in violation of the Public Readiness and Emergency Preparedness Act, 42 U.S.C. § 247d-6d. The Sookras also brought state-law tort claims against those defendants, as well as the physician who vaccinated and treated Taylor, and the pediatric practice where he worked.

The district court dismissed the federal-law claims on the grounds of sovereign immunity or lack of exhaustion of administrative remedies, and it declined to exercise supplemental jurisdiction over the remaining state-law claims. The Sookras appeal, challenging the dismissal of their claims against Pfizer and the government on the ground, among others, that the law required that the decision whether to dismiss the complaint be made by a three-judge court.

Because the Sookras’ federal-law claims could not be

 Circuit Judge Walker was a member of the panel at the time the case was argued but did not participate in the opinion. 3 dismissed by a single-judge court, we vacate the district court’s judgment and remand with directions for the district court to initiate the procedures to convene a three-judge court under 42 U.S.C. § 247d-6d(e)(5). We do not reach the Sookras’ remaining challenges.

I

A

In 2005, Congress enacted the Public Readiness and Emergency Preparedness Act (“PREP Act”) to encourage the rapid deployment of medical countermeasures during public health emergencies. See 42 U.S.C. §§ 247d-6d, 247d-6e; Cannon v. Watermark Ret. Cmtys., Inc., 45 F.4th 137, 139 (D.C. Cir. 2022). The PREP Act authorizes the Secretary of Health and Human Services to issue a declaration identifying a public health emergency and recommending the development of one or more medical “countermeasures.” 42 U.S.C. § 247d- 6d(b)(1). When the Secretary issues such a declaration, the Act immunizes certain “covered person[s]” from “suit and liability under Federal and State law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a covered countermeasure[.]” Id. § 247d-6d(a)(1).

Recognizing that PREP Act immunity may cut off relief that is otherwise available to individuals who are harmed by a covered countermeasure, Congress provided two avenues of redress.

First, the PREP Act provides a federal cause of action against covered persons “for death or serious physical injury” that is proximately caused by “willful misconduct.” 42 U.S.C. § 247d-6d(d)(1). A plaintiff bringing a willful-misconduct 4 claim, though, must follow a “carefully limited procedural path[.]” Cannon, 45 F.4th at 139. Among other requirements, “such actions * * * must be filed in the [United States District Court for the District of Columbia] and are subject to special pleading, discovery, and damages limitations.” Id.; see 42 U.S.C. § 247d-6d(e)(1)–(9). In addition, the PREP Act provides that “[a]ny” willful-misconduct action “shall be assigned initially to a panel of three judges[,]” which “shall have jurisdiction over such action for purposes of considering motions to dismiss, motions for summary judgment, and matters related thereto.” 42 U.S.C. § 247d-6d(e)(5).

Second, Congress established the Covered Countermeasure Process Fund, from which harmed individuals or their representatives may apply for compensation. 42 U.S.C. § 247d-6e(a). If the Secretary determines that an individual qualifies for compensation, that individual either may accept the offered compensation and forgo a willful-misconduct claim, or may reject the offer and sue. Id. § 247d-6e(d)(5). The PREP Act further provides that, with certain exceptions, a plaintiff may not bring a willful-misconduct action “unless such individual has exhausted” the available administrative remedies by applying for compensation from the Fund. Id. § 247d-6e(d)(1).

B

In March 2020, the Secretary of Health and Human Services issued a PREP Act declaration to provide “liability immunity for activities related to medical countermeasures against COVID-19.” Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15,198, 15,198 (March 17, 2020). The covered countermeasures include “any vaccine” used to treat or prevent COVID-19. Id. 5 at 15,201–15,202. As all parties in this case agree, Pfizer’s COVID-19 vaccine is a “covered countermeasure” within the meaning of the March 2020 declaration.1

In July and August 2021, Taylor received two doses of Pfizer’s COVID-19 vaccine from Dr. Mitchell Weiler at South Island Pediatrics in Cedarhurst, New York. J.A. 70. Four months later, in December 2021, Taylor began experiencing flu-like symptoms and sought treatment from Dr. Weiler. J.A. 70. Taylor seemed to be recovering well, but she then took a turn for the worse. On December 25th, Taylor was found unresponsive by her mother and taken to the hospital, where she was pronounced dead. J.A. 70. The Medical Examiner reported her cause of death as acute cardiac failure due to myocarditis (inflammation of the heart muscle), adding that “COVID-19 infection with pneumonitis” (inflammation of lung tissue) was a “significant condition.” J.A. 70 (formatting modified).

C

Taylor’s parents, Mr. Sookra and Ms. Burch-Sookra, filed suit in the United States District Court for the Eastern District of New York, asserting both state- and federal-law claims against Pfizer, the Secretary of Health and Human Services, and the Berkeley Carroll School (which had required the vaccination of its students, including Taylor). See Compl. at

1 See Second Am. Compl. at 3, Sookra, No. 24-cv-1249, ECF No.

Free access — add to your briefcase to read the full text and ask questions with AI

Arthur Sookra v. Pfizer Inc., (D.C. Cir. 2026).

Arthur Sookra v. Pfizer Inc. (Arthur Sookra v. Pfizer Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Swift & Co. v. Wickham
382 U.S. 111 (Supreme Court, 1965)
Goosby v. Osser
409 U.S. 512 (Supreme Court, 1973)
Gonzalez v. Automatic Employees Credit Union
419 U.S. 90 (Supreme Court, 1974)
McLucas v. DeChamplain
421 U.S. 21 (Supreme Court, 1975)
Arbaugh v. Y & H Corp.
546 U.S. 500 (Supreme Court, 2006)
Wertheimer v. Federal Election Commission
268 F.3d 1070 (D.C. Circuit, 2001)
United States Ex Rel. Totten v. Bombardier Corp.
380 F.3d 488 (D.C. Circuit, 2004)
Mississippi Ex Rel. Hood v. AU Optronics Corp.
134 S. Ct. 736 (Supreme Court, 2014)
Shapiro v. McManus
577 U.S. 39 (Supreme Court, 2015)
Kingdomware Technologies, Inc. v. United States
579 U.S. 162 (Supreme Court, 2016)
Gvt. Province of Manitoba v. David Bernhardt
923 F.3d 173 (D.C. Circuit, 2019)
Deborah Pueschel v. Elaine Chao
955 F.3d 163 (D.C. Circuit, 2020)
Community Oncology Alliance v. OMB
987 F.3d 1137 (D.C. Circuit, 2021)
Babb v. Wilkie
589 U.S. 399 (Supreme Court, 2020)